KOMPAS.com – The Indonesian Ministry of Health plans to start introducing the dengue or dengue fever vaccine starting next year.
For your information, dengue hemorrhagic fever (DHF) is a disease transmitted through the bite of the Aedes aegypti mosquito. Dengue fever is common in the rainy season.
Also read: How many doses of dengue fever vaccine are needed to prevent dengue fever?
Symptoms of dengue fever include sudden high fever reaching 40 degrees Celsius, severe headaches, muscle aches, nausea, vomiting, chronic fatigue, decreased appetite and vomiting of blood.
DHF can cause life-threatening complications, such as bleeding, lack of oxygen, and damage to vital organs, such as the lungs, liver, heart and brain.
Seeing the danger caused by dengue fever, we need to take precautions, one of which is the dengue vaccine.
The Indonesian Ministry of Health has scheduled the introduction of the dengue vaccine next year
Director General of Disease Prevention and Control at the Ministry of Health, Maxi Rein Rondonuwu, has scheduled the introduction of the dengue vaccine to become a national program to prevent the spread of dengue fever starting in 2025.
“We will discuss it with ITAGI (Indonesia Technical Advisory Group of Immunization). Of course we have to talk with ministries such as Bappenas, because it is related to financing, because for every new vaccine we have to start with introduction. (For the introduction of the dengue vaccine) we will see next year,” he said Maxi, reported by Antara, Wednesday (17/1/2024).
Maxi said that although he scheduled the introduction of the vaccine next year, the Government, he added, was also allowing regions with good Regional Revenue and Expenditure Budget (APBD) fiscal capacity to start introducing the dengue vaccine.
“We have also allowed regions, in fact the introduction has started in certain regions with good APBD fiscal capacity, such as East Kalimantan. Regions that are willing are welcome,” he said.
Also read: 7 Characteristics of Hemorrhagic Fever in Adults
For your information, the dengue hemorrhagic fever vaccine, also known as Travalent Dengue Vaccine (TDV), has been approved for distribution by the Food and Drug Supervisory Agency (BPOM).
According to the Association of Indonesian Internal Medicine Experts (PAPDI), the dengue fever vaccine is given in two doses from the age of six years to 45 years as a prevention of dengue fever.
The distance between the first and second vaccines is three months. After that, giving a repeat vaccine four years later is not necessary because antibodies are still high.
Prospective dengue vaccine recipients should be in good health and not allergic to the vaccine.
The dengue fever vaccine is also not recommended for people with weak immune systems, such as pregnant, breastfeeding women and HIV sufferers.
People who are treated with high doses of steroids and immunotherapy are also not recommended to be injected with the dengue fever vaccine.
Also read: Get to know the 3M Plus Principles for Preventing Dengue Hemorrhagic Fever
Get selected news updates and breaking news every day from Kompas.com. Let’s join the Telegram Group “Kompas.com News Update”, by clicking the link https://t.me/kompascomupdate, then join. You must install the Telegram application first on your cellphone.
2024-01-17 23:25:00
#Ministry #Health #Schedules #Introduction #Dengue #Fever #Vaccine #Year #Kompas.com
